The CYP3A1mRNA and protein expressions in the small intestine and the liver (n = 3). by Xiangchen Li (512737)

Subjects:

Phospho-deficient Akt2 T309A/S474A prevents TGFβ induced decrease in deptor and activation of mTORC1 and mTORC2. by Falguni Das (161719)

Pharmacological inhibition of pulmonary sensory neuron activity during IAV infection increases morbidity. by Nathalie A. J. Verzele (18389733)

Confirmation of AAV encoding Cre-inducible diphtheria toxin (AAVrg^{mCh FLEX DTA}) fucntionality. by Nathalie A. J. Verzele (18389733)

Transfection of mature dendritic cells (mDC) with increasing amounts of SOCS-1 encoding plasmid induces a decrease of CYTIP expression. by Daniela Grabher (383863)

“…One representative Western blot is shown. iDC: immature dendritic cells, mDC: mature dendritic cells, mock: transfection procedure without plasmid DNA, µg indicate the amount of plasmid used for transfection. CYTIP expression decreases significantly with SOCS-1 over expression 16 hours after transfection with 4 and 8 µg of SOCS-1 encoding plasmid.…”

A decrease in the proportion of immunoregulatory islet resident macrophages relative to immunostimulatory islet resident DCs heralds T1D in NOD mice. by Thomas B. Thornley (2550766)

Image_3_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF by Rohit Moudgil (540119)

Image_13_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF by Rohit Moudgil (540119)

Presentation_1_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.pdf by Rohit Moudgil (540119)

Image_11_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIF by Rohit Moudgil (540119)

Image_4_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF by Rohit Moudgil (540119)

Image_7_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIF by Rohit Moudgil (540119)

Image_8_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIF by Rohit Moudgil (540119)

Image_6_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIF by Rohit Moudgil (540119)

Image_5_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIF by Rohit Moudgil (540119)

Image_10_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIF by Rohit Moudgil (540119)

Image_12_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF by Rohit Moudgil (540119)

Image_15_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF by Rohit Moudgil (540119)

Image_1_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF by Rohit Moudgil (540119)

Image_9_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIF by Rohit Moudgil (540119)